In a report published Tuesday, Sterne Agee analyst Gregory P. Chodaczek initiated coverage on Greatbatch GB with a Buy rating and $53.00 price target.
In the report, Sterne Agee noted, “Greatbatch, Inc. is a leader in critical technologies serving four large and growing medical device markets which have a combined worldwide market opportunity of over $6.5 billion. Over the past eight years, Greatbatch has not only diversified and grown its revenue (16% CAGR), it has also increased its operating efficiencies. What was once a company focused primarily on cardiac rhythm management (CRM) devices is now a diversified medical devices and components company.”
Greatbatch closed on Monday at $46.33.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in